Grovepoint Capital
| Industry | Private equity |
|---|---|
| Founded | 2010 |
| Founder | Leon Blitz Bradley Fried |
| Headquarters | London, NW1 United Kingdom |
| Website | grovepoint.co.uk |
Grovepoint Capital is a private equity firm headquartered in London, United Kingdom.[1] It has additional offices in Israel.[1] It was co-founded by Leon Blitz and Bradley Fried in 2010.[1][2][3] In 2013, it acquired Algatechnologies, an Israeli biotech start-up, for $15 million-$20 million.[3]
References
- ^ a b c "Company Overview of Grovepoint Capital LLP". Bloomberg Business. Retrieved October 16, 2015.
- ^ Denham, Annabelle (November 18, 2013). "Startup springboks who let the idea come to them". City A.M. Retrieved October 16, 2015.
- ^ a b Bar-Eli, Avi (February 10, 2013). "U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies: Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging". Haaretz. Retrieved October 16, 2015.
 | This London-related article is a stub. You can help Wikipedia by expanding it. |